Depression

Mid-life can be the linchpin to a score of depression complaints. Diminished hormones combined with poor lifestyle choices and dramatic, stressful changes in a patient’s personal or work life produce a litany of emotional upheavals. Exercise—running, swimming, dancing—as well as appropriate hormonal modulation may help restore youthful levels and create a beneficial impact on patients wrestling with depression. Review current research and medical articles on depression and these therapeutic approaches.


Hormones and Sexuality During Transition to Menopause.pdf

This study confirms the observation that sexual dysfunction increases over the menopausal transition. Several factors associated with sexual dysfunction include low DHEAS, absence of a sexual partner, anxiety, and children under the age of 18 living at home.
Gracia, C.R., Freeman, E.W., Sammel, M.D., Lin, H. & Mogul, M. (2007). Hormones and sexuality during transition to menopause [Electronic version]. Obstetrics and Gynecology, 109(4), 831-840. Retrieved May 31, 2007.

Male Menopause.pdf

According to this article, women may not be the only ones who suffer the effects of changing hormones. Some doctors are noticing that their male patients are reporting some of the same symptoms that women experience in menopause.
(2006, April 5). Male menopause [Electronic version]. Cleveland Clinic Website. Retrieved May 2, 2007.

Don’t Call it Male Menopause.pdf

As men start to age, their bodies also start to undergo major changes. They don't get hot flashes, but they do experience hormonal, physiological and chemical shifts that can affect many aspects of their lives. This article suggests that you can call it aging; just don't call it male menopause.
Yara, S. (2006, September 28). Don’t call it male menopause [Electronic version]. Forbes.com Website. Retrieved May 2, 2007.

Prevalence of Hypogonadism in Males Aged at Least 45 Years: The HIM study.pdf

According to this study, based on TT concentration, the prevalence of hypogonadism in men reporting to primary care offices was estimated to be 38.7%. The medical conditions that occurred significantly more frequently among hypogonadal men than eugonadal men included increased BMI, hypertension, hyperlipidaemia, diabetes, and asthma or COPD. As men age, they are susceptible to conditions that share many of the same symptoms similar to hypogonadism. The presence of these conditions may, in effect, mask underlying hypogonadism and negatively impact quality of life.
Mulligan, T., Frick, M.F., Zuraw, Q.C., Stemhagen, A. & McWhirter, C. (2006). Prevalence of hypogonadism in males aged at least 45 years: the HIM study [Electronic version]. International Journal of Clinical Practice, 60(7), 762-769. Retrieved November 27, 2006.

Hormone Profiles After Intramuscular Injection of Testosterone Enanthate in Patients with Hypogonadism.pdf

To examine hormone levels after androgen replacement therapy (ART) in Japanese male patients with hypogonadism, nine Japanese male patients with hypogonadism (serum total testosterone (tT) or free testosterone (fT) levels of < or = 2.7 ng/mL or < or = 10 pg/mL, respectively; average age, 59 years) were enrolled.
Nakazawa, R., Baba, K., Nakano, M., Katabami, T., Saito, N., Takahashi, T., et al. (2006). Hormone profiles after intramuscular injection of testosterone enanthate in patients with hypogonadism  [Electronic version]. Endocrine Journal, 53(3), 305-310. Epub May 19, 2006. Retrieved November 27, 2006.

Management of Andropause: The Male Menopause.pdf

According to this article, andropause is a syndrome of physical, sexual, and psychological symptoms in aging men due to a gradual decline in serum testosterone levels. Its symptoms are more prominent in the presence of concomitant medical disorders. Testosterone replacement therapy relieves these symptoms along with improvement in bone and muscle mass, sexual function, and quality of life.
Tunuguntla, H.S.G.R. (2005, November), Management of andropause: the male menopause [Electronic version]. Clinical Geriatrics, 13(11), 27-34. Retrieved May 2, 2007.

DHEA May Help Midlife Depression. Conventional Antidepressants Still the First Line of Defense, Says Study.pdf

The hormonal supplement DHEA could help relieve mild to moderate depression that starts in middle age, new research shows.
Hitti, M. (2005, February 7). DHEA may help midlife depression. Conventional antidepressants still the first line of defense, says study [Electronic version]. WebMD Medical News. Retrieved November 8, 2005.

Workouts Can Lighten Heavy Hearts.pdf

According to this article, the millions of Americans stricken each year by debilitating depression may want to consider running away from their problem -- or walking, swimming or dancing it away.
Mundell, E.J. (2005, November 6). Workouts can lighten heavy hearts [Electronic version]. HealthDay News. Retrieved November 8, 2005.

Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression.pdf

This study found DHEA to be an effective treatment for midlife-onset major and minor depression.
Schmidt, P.J., Daly, R.C., Bloch, M., Smith, M.J., Danaceau, M.A., St. Clair, L.S., et al. (2005). Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression [Electronic version]. Archives of General Psychiatry, 62(2), 154-162. Retrieved November 18, 2005.

One Year Follow-up Study of the Association Between Chemical Castration, Sex Hormones, Beta-Amyloid, Memory and Depression in Men.pdf

The results of this naturalistic study indicate that chemical castration is associated with a significant rise in the plasma levels of Abeta and, clinically, with increased depression and anxiety scores. The discontinuation of treatment is associated with better cognitive performance, most noticeably of verbal memory. The performance of subjects on the WL test was negatively correlated with plasma levels of Abeta, but the clinical significance of this finding remains to be determined.
Almeida, O.P., Waterreus, A., Spry, N., Flicker, L. & Martins, R.N. (2004). One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men [Electronic version]. Psychoneuroendocrinology, 29(8), 1071-1081. Retrieved November 18, 2005.

Low Testosterone Common in Type 2 Diabetes Study: 1 in 3 Diabetic Men May Suffer Low Sex Hormone Levels.pdf

A third of men with type 2 diabetes have low testosterone levels, a new study suggests. Testosterone helps men reduce body fat and improves the way their bodies handle insulin. So low testosterone levels may have serious consequences for men with diabetes, suggests Sandeep Dhindsa, MD, of State University of New York at Buffalo.
DeNoon, D. (2004, December 1). Low testosterone common in type 2 diabetes
study: 1 in 3 diabetic men may suffer low sex hormone levels. WebMD Health. Retrieved December 12, 2006.

The Women’s Health Initiative 2004 – Review and Critique.pdf

This article reviews the published results from the Women’s Health Initiative (WHI) and their various interpretations. The WHI was designed to define the risks and benefits of interventions, notably hormone therapy, to potentially prevent heart disease, breast and colorectal cancer, and osteoporotic fractures in postmenopausal women.
Goldman, J.A. (2004). The Women’s Health Initiative 2004 – Review and Critique [Electronic version]. Medscape General Medicine, 6(3). Retrieved September 27, 2005.

Review of the Book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.pdf

Review by Amazon.com of Suzanne Somers’ book The Sexy Years: Discover the Hormone Connection: The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men.
Lightner, J. (2004). [Review of the book The sexy years: Discover the hormone connection: the secret to fabulous sex, great health, and vitality, for women and men]. Retrieved September 10, 2004.

Quality of Life of Growth Hormone (GH) Deficient Young Adults During Discontinuation and Restart of GH Therapy.pdf

It is concluded that one year discontinuation of GH treatment leads to a decrease in QoL within 6 months which effect is counteracted within 6 months after restart of GH treatment.
Stouthart, P.J., Deijen, J.B., Roffel, M. & Delemarre-van de Waal, H.A. (2003). Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy [Electronic version]. Psychoneuroendocrinology, 28(5), 612-626. Retrieved December 7, 2005.

Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia.pdf

The preliminary observations report for the first time in double-blind fashion the efficacy of DHEA augmentation in the management of negative, depressive, and anxiety symptoms of schizophrenia. The findings from this study raise important issues regarding the role of neurosteroids in general, and DHEA in particular, in the ongoing symptomatology and pharmacotherapy of schizophrenia.
Strous, R.D., Maayan, R., Lapidus, R., Stryjer, R., Lustig, M., Kotler, M., et al. (2003). Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia [Electronic version]. Archives of General Psychiatry, 60(2), 133-141. Retrieved December 7, 2005.

Single and Combined Effects of Growth Hormone and Testosterone Administration on Measures of Body Composition, Physical Performance, Mood, Sexual Function, Bone Turnover, and Muscle Gene Expression in Healthy Older Men.pdf

This study examined the effects of GH and/or testosterone (T) administration on body composition, performance, mood, sexual function, bone turnover, and muscle-gene expression in healthy older men. It concluded that 1 month of GH and/or T administration improves certain measures of balance and physical performance in older men and increases muscle IGF-I gene expression.
Brill, K.T., Weltman, A.L., Gentili, A., Patrie, J.T., Fryburg, D.A., Hanks, J.B., et al. (2002). Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 87(12), 5649-5657. Retrieved January 4, 2006.

Do Omega-3 Fatty Acids Help in Depression?. pdf

This study concluded that despite observational evidence linking depression with reduced intake of long-chain omega-3 fatty acids, there is no convincing basis for using these nutrients as a sole treatment for the condition. There is limited evidence suggesting that long-chain omega-3 fatty acid supplements might help to relieve depression when given in addition to existing antidepressantmedication. However, this needs confirming before they can recommend the routine use of such supplements in patients with depression.
(2000, February). Do omega-3 fatty acids help in depression? [Electronic version]. Drug and Therapeutics Bulletin, 45(2), 9-12. Retrieved May 14, 2007.

Growth Hormone Replacement in Adults with Growth Hormone Deficiency: Assessment of Current Knowledge.pdf

This article states that recent availability of recombinant human growth hormone (GH) has led to intense investigation of the consequences of adult GH deficiency (GHD) and the effects of GH replacement. These studies have led to the identification of a characteristic syndrome of GHD consisting of decreased mood and well-being, with alterations in body composition and substrate metabolism.
Carroll, P.V., Christ, E.R. & Sonksen, P.H. (2000). Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge [Electronic version]. Trends in Endocrinology and Metabolism, 11(6), 231-238. Retrieved January 18, 2006.

The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male--Is There a Link?.pdf

The objective of this study was to review the literature on the hormonal changes that occur in aging males in order to determine if testosterone declines in relation to depressed mood and if testosterone might prove useful in treatment of depression.
Margolese, H.C. (2000). The male menopause and mood: testosterone decline and depression in the aging male--is there a link? [Electronic version]. Journal of Geriatric Psychiatry and Neurology, 13(2), 93-101. Retrieved October 3, 2005.

Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study.pdf

According to this study, it is biologically plausible that testosterone has an effect on depression. As reviewed elsewhere, androgen and estrogen binding sites overlap in the brain. Testosterone in the brain is extensively converted to estradiol and DHT, which binds to androgen receptors. The complete absence of an association between circulating estradiol and mood scores makes the thesis that the testosterone mood association is mediated by aromatization to estradiol unattractive but does not entirely exclude it. Clinical trials are needed to further assess this association.
Barrett-Connor, E., von Muhlen, D.G., & Kritz-Silverstein, D. (1999). Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 84 (2), 573-577. Retrieved July 21, 2003.

Endogenous Levels of Dehydroepiandrosterone Sulfate, but Not Other Sex Hormones, Are Associated with Depressed Mood in Older Women: The Rancho Bernardo Study.pdf

The purpose of this study was to determine whether endogenous steroid hormone levels are associated with depressed mood in community-dwelling older women. These results add to the evidence that DHEA/S is a neuroactive steroid and point to the need for careful long-term clinical trials of DHEA therapy in older women with depressed mood.
Barrett-Connor, E., von Muhlen, D., Laughlin, G.A. & Kripke, A. (1999). Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study [Electronic version]. Journal of the American Geriatric Society, 47(6), 685-691. Retrieved September 14, 2005.

The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients.pdf

This study concluded that GH treatment for 10 yr in GHD adults resulted in increased lean body and muscle mass, a less atherogenic lipid profile, reduced carotid intima media thickness, and improved psychological well-being.
Gibney, J., Wallace, J.D., Spinks, T., Schnorr, L., Ranicar, A., Cuneo, R.C., et al. (1999). The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients [Electronic version]. The Journal of Clinical Endocrinology and Metabolism, 84(8), 2596-2602. Retrieved January 25, 2006.

Health Benefits of Docosahexaenoic Acid (DHA).pdf

Fish oil decreases the proliferation of tumour cells, whereas arachidonic acid, a longchain n-6 fatty acid, increases their proliferation. These opposite effects are also seen with inflammation, particularly with rheumatoid arthritis, and with asthma. DHA has a positive effect on diseases such as hypertension, arthritis, atherosclerosis, depression, adult-onset diabetes mellitus, myocardial infarction, thrombosis, and some cancers.
Horrocks, L.A. & Yeo, Y.K. (1999). Health benefits of docosahexaenoic acid (DHA) [Electronic version]. Pharmacological Research, 40(3), 211-225. Retrieved September 16, 2005.

Neuroactive Steroids: Mechanisms of Action and Neuropsychopharmacological Perspectives.pdf

This article describes how neuroactive steroids modulate neurotransmitter receptors and addresses the neuropsychopharmacological potential that arises from the intracellular crosstalk between genomic and nongenomic steroid effects. Neuroactive steroids could also have a role in the response to stress and the treatment of psychiatric disorders, such as depression, and, as they affect a broad spectrum of behavioral functions through their unique molecular properties, they could constitute a yet unexploited class of drugs.
Rupprecht, R. & Holsboer, F. (1999). Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosciences, 22(9), 410-416. Retrieved October 3, 2005.

Double-Blind Treatment of Major Depression with Dehydroepiandrosterone.pdf

These results of this study suggest that DHEA treatment may have significant antidepressant effects in some patients with major depression. Further, larger-scale trials are warranted.
Wolkowitz, O.M., Reus, V.I., Keehler, A., Nelson, N., Friedland, M., Brizendine, L., et al. (1999). Double-blind treatment of major depression with dehydroepiandrosterone [Electronic version]. The American Journal of Psychiatry, 156 (4), 646-649. Retrieved July 23, 2003.

DHEA: A Biologist's Perspective.pdf

According to the author, it has been proposed that replacement therapy with DHEA to restore youthful levels of DHEAS in older individuals might have beneficial effects on a variety of age-related conditions, such as cardiovascular and neoplastic diseases, diabetes, immune dysfunction, muscular weakness, and depression.
Hornsby, P.J. (1997). DHEA: a biologist's perspective [Electronic version]. Journal of the American Geriatrics Society, 45(11), 1395-1401. Retrieved January 19, 2006.